Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Gerontology & Geriatric Medicine|April 18, 2022
A Comprehensive Oral Intake Evaluation Tool (the Kuchi-kara Taberu Index) Facilitated Functional Eating Rehabilitation: A Case Report in a Frail Older Patient with Malnutrition and Suspected Iatrogenic SarcopeniaYoshifumi Hidaka, Satomi Watanabe, Yumiko Nishikawa, et al.
Investigational New Drugs|July 31, 2025
Pharmacokinetics, efficacy and safety of palbociclib and fulvestrant in a patient with hormone receptor-positive, human epidermal growth factor receptor 2 negative metastatic breast cancer with end-stage renal disease undergoing hemodialysis: A case reportToshiaki Takakura, Tsutomu Iwasa, Chiyo K Imamura, et al.
Applied and Environmental Microbiology|November 20, 2025
Characterization of the initial degradation mechanism involved in C-glycosylated isoflavone puerarin in soil microorganismTakuto Kumano, Satomi Watanabe, Masakazu Kusakari, et al.
Investigational New Drugs|August 31, 2021
Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifenKohsuke Isomoto, Koji Haratani, Satomi Watanabe, et al.
International Archives of Allergy and Immunology|November 24, 2021
Juzentaihoto Exerts Anti-Allergic Effects by Inhibiting Effector T-Cell Activation and Inducing and/or Activating Regulatory T Cells in a Murine Model of Contact HypersensitivityAtsushi Tsuge, Sho Yonekura, Satomi Watanabe, et al.
Phytochemistry|October 17, 2003
Changes in lignin content of leaf litters during mulchingZhenfu Jin, Takuya Akiyama, Byung Yeoup Chung, et al.
The Oncologist|July 29, 2025
Clinical and molecular landscape of metastatic extramammary Paget's diseaseSatomi Watanabe, Koji Haratani, Tomohiro Nakayama, et al.
Thoracic Cancer|July 9, 2021
Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplicationEsuteru Hirokawa, Satomi Watanabe, Kazuko Sakai, et al.
Clinical Lung Cancer|June 20, 2016
Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and AlectinibSatomi Watanabe, Hidetoshi Hayashi, Kunio Okamoto, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
Psychosocial effects of appearance changes due to cancer treatment and needs for information and supportive care in Japanese cancer patientsHitomi Sakai, Atsuko Koyama, Kaoru Tanaka, et al.
Pageof 3